title: ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins.
authors.forename: Richard C
authors.initials: RC
authors.lastname: Pasternak
authors.forename: Sidney C
authors.initials: SC
authors.lastname: Smith
authors.forename: C Noel
authors.initials: CN
authors.lastname: Bairey-Merz
authors.forename: Scott M
authors.initials: SM
authors.lastname: Grundy
authors.forename: James I
authors.initials: JI
authors.lastname: Cleeman
authors.forename: Claude
authors.initials: C
authors.lastname: Lenfant
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000075202:Contraindications; D003327:Coronary Disease / Q000188:drug therapy; D003402:Creatine Kinase / Q000097:blood; D004347:Drug Interactions; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic; D009135:Muscular Diseases / Q000139:chemically induced / Q000517:prevention & control; D011725:Pyridines / Q000009:adverse effects / Q000627:therapeutic use; D012307:Risk Factors
chemical_list: D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011725:Pyridines; C086276:cerivastatin; D003402:Creatine Kinase